Hypertension is highly prevalent, with 30% of American adults having hypertension. About half of hypertensive adults in the US have their blood pressure under control while the other half remain at an unhealthy level.
While antihypertensive drugs have been the primary available treatment option, the high rate of uncontrolled blood pressure suggests alternative therapies are needed. In fact, a recent NIH study called “SPRINT” reports that more intensive therapy aimed at lower blood pressure goals has significant health benefits in reducing cardiovascular disease and stroke. It seems clear that tighter blood pressure control will become the standard of care.
eCoin is a viable alternative therapy for the treatment of hypertension. Tested in a rigorous OUS study involving a modest 48 patients, eCoin appears safe, effective, and well-liked by patients. However, a larger US study involving several hundred patients, whose purpose is to show both clinical and statistical significance, will be required for FDA approval of eCoin.